2021 Outlook: COVID-19’s Impact on Procedure Volumes

With COVID-19 continuing to create uncertainty, Guidepoint Qsight has gathered insights from U.S. physicians across healthcare markets on their expected change in procedure volumes at their facility in 2021.

Collectively, over half of all physicians believe they will see higher procedure volumes in 2021 than they did in 2020.

The Aesthetics market has the highest hopes for a rebound, with 63% of physicians expecting an increase in procedure volume in 2021 and only 17% expecting a decrease.

Physicians in the Musculoskeletal Market are more divided in their volume expectations for 2021, with an average of 55% expecting an increase in procedure volumes and 35% expecting a decrease.

Interventional Cardiology and Cardiac Rhythm Management physicians are the least likely to expect a decrease in their 2021 procedure volumes, with 41% on average expecting 2021 to be about the same as 2020.

The above is based on primary survey data gathered from a proprietary panel of physicians from 300+ unique healthcare sites performing medical procedures on a monthly basis. To learn more about Qsight’s insight into recent trends amid COVID-19, click here.

Post created by: Harsh Trivedi, Senior Healthcare Analyst, Guidepoint Qsight, Travis Deseran, Director of Quantitative Research, Guidepoint Qsight and Shimul Sheth, Senior Quantitative Analyst, Guidepoint Qsight

Leave a comment

Privacy Preferences
When you visit our website, it may store information through your browser from specific services, usually in form of cookies. Here you can change your privacy preferences. Please note that blocking some types of cookies may impact your experience on our website and the services we offer.